All News & Press

November 23, 2020

CordenPharma COVID-19 Customer Letter

November 23, 2020
COVID-19 > Read CEO Dr. Micheal Quirmbach's Customer Letter Response to COVID-19.
November 17, 2020

Peptide Manufacturing Capacity Increasing in 2021

November 17, 2020
Press Release > CordenPharma Increases Centre of Excellence for Peptide Development Capacity.
November 16, 2020

Moderna Positive Phase 3 Results of mRNA-1273 Vaccine Candidate

November 16, 2020
News > CordenPharma Congratulates Moderna on positive Phase 3 results of mRNA-1273 COVID-19 vaccine.
October 23, 2020

Coronavirus Challenges & Opportunities

October 23, 2020
Article Interview > CHEManager Interviews Dr. Michael Quirmbach on the Coronavirus Opportunities for CDMOs
October 19, 2020

CordenPharma Colorado Completes Highly Potent API Expansion

October 19, 2020
Press Release > CordenPharma Colorado Completes Highly Potent API Laboratory Expansion
October 8, 2020

COVID-19 Affect on CDMO Pharma Services

October 8, 2020
Article Contribution > For Pharmaceutical services, it’s the best of times in the worst of times
October 7, 2020

Flexible Aseptic Filling Solutions Required

October 7, 2020
Article > Filling in: How Stevanato Group Supports Cordenpharma's Expansion
September 29, 2020

COO On Expanded Digitalization

Edition 3 / September 2020
Editorial > How Increasing Digitalization Affects Daily Business in Q3 & Beyond
September 29, 2020

Lessons Learned From Conducting Remote Audits

Edition 3 / September 2020
Article > Successful Remote Audits & Inspections: Focusing On the Human Factor
September 29, 2020

We’re Going Virtual – CPhI & Injectable Webinar

Edition 3 / September 2020
Article > We’re Going Virtual: CPhI Festival of Pharma & Injectable Live Webinar
September 29, 2020

Creating a Customer-CDMO Win-Win

Edition 3 / September 2020
Article > What Makes a Good Customer?
September 21, 2020

Webinar – Your Injectable Roadmap for Combination Products

September 21, 2020
Webinar On Demand > Your Injectable Roadmap for Device-Drug Regulations & Capabilities in the New Normal
July 7, 2020

CDMO Expands US Peptide Manufacturing Capacity

July 07, 2020
Press Release > CordenPharma Increases US Peptide Manufacturing Capacity to Accommodate Global Market Growth
June 30, 2020

Molecule to Market Podcast: A CDMO on the Covid-19 frontline

June 30, 2020
Molecule to Market Podcast: A CDMO on the COVID-19 Frontline, with guest Dr. Michael Quirmbach
June 10, 2020

Adopting Virtual Tools in COVID-19 New Normal

Edition 2 / June 2020
Editorial > CordenPharma Navigates COVID-19 Towards “The New Normal”